Study title: Clinical study to investigate the efficacy, safety and immunogenicity of Wilate in children < 6 years of age with inherited von willebrand disease.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Hemic and Lymphatic Diseases | |||||
Brands: | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: VON WILLEBRAND FACTOR AND COAGULATION FACTOR VIII IN COMBINATION | |||||
ATC code: B02BD06 | |||||
Document link: | |||||
Document date: | |||||
Study number: WIL-14 | |||||
EudraCT number: 2005-001426-84 | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |